Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Grochow

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high-grade gliomasS A Grossman, S Phuphanich, G Lesser, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignanciesR A Larson, R B Geller, L Janisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic studyE K Rowinsky, S D Baker, K Burks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumorsE C Dees, L R Whitfield, W R Grove, et al.
Oncology Nursing Forum|November 1, 1993
Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantationD B McGuire, V Altomonte, D E Peterson, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancerD L Trump, J A Hathorn, L B Grochow, et al.
Investigational New Drugs|November 1, 1989
Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I studyE K Rowinsky, L B Grochow, A Hantel, et al.
AJR. American Journal of Roentgenology|April 1, 1993
Misperfusion of the liver during hepatic artery infusion chemotherapy: value of preoperative angiography and postoperative pump scintigraphyA C Civelek, J V Sitzmann, B B Chin, et al.
Investigational New Drugs|August 1, 1990
Phase II trial of menogaril as initial chemotherapy for metastatic breast cancerM J Kennedy, R C Donehower, L B Grochow, et al.
Cancer Research|November 1, 1987
Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological studyE K Rowinsky, D S Ettinger, W P McGuire, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high-grade gliomasS A Grossman, S Phuphanich, G Lesser, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignanciesR A Larson, R B Geller, L Janisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic studyE K Rowinsky, S D Baker, K Burks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumorsE C Dees, L R Whitfield, W R Grove, et al.
Oncology Nursing Forum|November 1, 1993
Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantationD B McGuire, V Altomonte, D E Peterson, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancerD L Trump, J A Hathorn, L B Grochow, et al.
Investigational New Drugs|November 1, 1989
Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I studyE K Rowinsky, L B Grochow, A Hantel, et al.
AJR. American Journal of Roentgenology|April 1, 1993
Misperfusion of the liver during hepatic artery infusion chemotherapy: value of preoperative angiography and postoperative pump scintigraphyA C Civelek, J V Sitzmann, B B Chin, et al.
Investigational New Drugs|August 1, 1990
Phase II trial of menogaril as initial chemotherapy for metastatic breast cancerM J Kennedy, R C Donehower, L B Grochow, et al.
Cancer Research|November 1, 1987
Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological studyE K Rowinsky, D S Ettinger, W P McGuire, et al.
Pageof 9